FDA Looking For Ways To Measure Pediatric Provision Success - Lumpkin
Executive Summary
FDA and the pharmaceutical industry must develop ways to assess whether the goals of FDAMA's pediatric provisions are being met, Center for Drug Evaluation & Research Deputy Director for Review Management Murray Lumpkin, MD, said.